Stem cell islet transplant for diabetes
Part of Hormones & metabolism clinical trials.
This study tests if islet cells made from stem cells can be safely transplanted to help control blood sugar in people with diabetes. It may offer a new treatment option for those who need insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had diabetes for more than 5 years
- Your body mass index (BMI) is between 18 and 35
- You currently use insulin therapy
- You do not have serious infections like HIV, hepatitis, or tuberculosis
- You do not have severe diabetes complications or a history of cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
This trial tests whether transplanting stem cells that can turn into insulin-producing cells helps people with type 1 diabetes manage their blood sugar. It may reduce the need for insulin injections.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This trial tests whether transplanting insulin-producing “islet” cells can better control blood sugar in people who have already received a kidney transplant. It’s mainly for adults with type 1 diabetes whose body is no longer making enough insulin, while they are on kidney-transplant medicines.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.